Detailed view for TGME49_259965
Basic information
Toxoplasma gondii, Bardet-Biedl syndrome 5, putative
Source Database / ID: ToxoDB
pI: 5.9292 |
Length (AA): 716 |
MW (Da): 77503 |
Paralog Number:
1181
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Network
Gene Ontology
Metabolic Pathways
Structural information
Modbase 3D models:
There are 6 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
| Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
|---|---|---|---|---|---|---|---|---|---|
| 307 | 384 | 1oqy (A) | 63 | 150 | 35.00 | 0.69 | 0.04 | 0.162239 | 1.62 |
| 492 | 661 | 4tmd (A) | 33 | 208 | 16.00 | 0 | 0.28 | 0.35263 | -0.18 |
| 516 | 630 | 2mqa (A) | 23 | 135 | 10.00 | 0 | 0 | 0.257815 | -0.57 |
| 667 | 706 | 5d0m (C) | 293 | 338 | 40.00 | 0 | 0.83 | 0.306066 | 1.09 |
| 668 | 706 | 2lxh (C) | 341 | 382 | 36.00 | 0 | 0.68 | 0.282669 | 0.99 |
| 668 | 709 | 2ma6 (A) | 11 | 55 | 40.00 | 0.096 | 0.41 | 0.312959 | 0.48 |
Help me make sense of these data.
Target End: last modeled residue
Template: template structure used for modelling (PDB accession and chain)
Template Beg: first template residue in target-template alignment
Template End: last template residue in target-template alignment
Identity: sequence identity
Evalue: E value for target-template hit
Model Score: GA341 score (>0.7 for reliable model)
MPQS: ModPipe Quality Score (>1.1 for reliable model)
zDope: zDope Score (negative for reliable model)
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Expression
| Upregulation Percent | Ranking | Stage | Dataset |
|---|---|---|---|
| NA% percentile | ME49 Tachyzoite. | Gregory |
| Upregulation Percent | Ranking | Stage | Dataset |
|---|---|---|---|
| Mid 40-60% percentile | ME49 merozoite, ME49 Oocyst. | Hehl AB Fritz HM |
| Upregulation Percent | Ranking | Stage | Dataset |
|---|---|---|---|
| Lower 0-20% percentile | VEG Tachyzoite, ME49 Bradyzoite. | Gregory Sibley/Greg |
-
Fritz HM Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. -
Sibley/Greg ToxoDB -
Gregory ToxoDB -
Hehl AB Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes.
Orthologs
Essentiality
Phenotypes and Validation (curated)
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Annotated validation
Associated compounds / Druggability
Known modulators for this target
Predicted associations
By orthology with druggable targets
By sequence similarity to non orthologous druggable targets
Obtained from network model
Assayability
Assay information
Reagent availability
Bibliographic References